Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1967 1
1968 1
1969 2
1971 3
1972 3
1973 1
1976 3
1978 3
1979 2
1981 1
1982 3
1983 2
1984 5
1985 6
1986 2
1987 3
1988 1
1990 1
1992 1
1994 1
1996 2
1998 2
1999 2
2000 1
2004 2
2005 2
2014 1
2015 3
2019 1
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Kohli A, Sarin S, Caldwell SH, Alkhouri N, Shiffman ML, Camargo M, Li G, Kersey K, Jia C, Zhu Y, Djedjos CS, Subramanian GM, Myers RP, Gunn N, Sheikh A, Anstee QM, Romero-Gomez M, Trauner M, Goodman Z, Lawitz EJ, Younossi Z; STELLAR-3; STELLAR-4 Investigators. Harrison SA, et al. J Hepatol. 2020 Jul;73(1):26-39. doi: 10.1016/j.jhep.2020.02.027. Epub 2020 Mar 6. J Hepatol. 2020. PMID: 32147362 Clinical Trial.
Alcoholic liver disease.
Pimstone NR, French SW. Pimstone NR, et al. Med Clin North Am. 1984 Jan;68(1):39-56. doi: 10.1016/s0025-7125(16)31240-8. Med Clin North Am. 1984. PMID: 6361417 Review.
Porphyria cutanea tarda.
Pimstone NR. Pimstone NR. Semin Liver Dis. 1982 May;2(2):132-42. doi: 10.1055/s-2008-1040703. Semin Liver Dis. 1982. PMID: 6753163 Review. No abstract available.
Current status of medical treatment of gallstones.
Pimstone NR, Mok HY. Pimstone NR, et al. Surg Clin North Am. 1981 Aug;61(4):865-74. doi: 10.1016/s0039-6109(16)42484-9. Surg Clin North Am. 1981. PMID: 7025296 Review.
Recommendations for the diagnosis and treatment of the acute porphyrias.
Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, Desnick RJ. Anderson KE, et al. Among authors: pimstone nr. Ann Intern Med. 2005 Mar 15;142(6):439-50. doi: 10.7326/0003-4819-142-6-200503150-00010. Ann Intern Med. 2005. PMID: 15767622 Review.
Renal degradation of hemoglobin.
Pimstone NR. Pimstone NR. Semin Hematol. 1972 Jan;9(1):31-42. Semin Hematol. 1972. PMID: 4553044 Review. No abstract available.
Fibrolamellar hepatocarcinoma: radiology, management, and pathology.
Wong LK, Link DP, Frey CF, Ruebner RH, Tesluk H, Pimstone NR. Wong LK, et al. Among authors: pimstone nr. AJR Am J Roentgenol. 1982 Jul;139(1):172-5. doi: 10.2214/ajr.139.1.172. AJR Am J Roentgenol. 1982. PMID: 6283868 No abstract available.
62 results